bf/NASDAQ:VYGR_icon.jpeg

COM:VOYAGERTHERAPEUTICS

Voyager Therapeutics

  • Stock

USD

Last Close

5.43

22/11 21:00

Market Cap

439.50M

Beta: -

Volume Today

359.89K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
17.33M
-
14.22M
17.96%
10.13M
28.73%
7.62M
24.82%
104.39M
1,270.14%
171.13M
63.93%
37.41M
78.14%
40.91M
9.33%
250.01M
511.16%
cost of revenue
4.44M
-
gross profit
17.33M
-
14.22M
17.96%
10.13M
28.73%
7.62M
24.82%
104.39M
1,270.14%
171.13M
63.93%
37.41M
78.14%
40.91M
9.33%
245.57M
500.31%
selling and marketing expenses
general and administrative expenses
5.47M
-
9.91M
81.18%
13.27M
33.92%
19.74M
48.74%
33.81M
71.29%
36.34M
7.47%
34.99M
3.70%
37.25M
6.44%
30.98M
16.82%
35.82M
15.63%
selling general and administrative expenses
5.47M
-
9.91M
81.18%
13.27M
33.92%
19.74M
48.74%
33.81M
71.29%
36.34M
7.47%
34.99M
3.70%
37.25M
6.44%
30.98M
16.82%
35.82M
15.63%
research and development expenses
8.90M
-
27.68M
211.07%
42.25M
52.64%
62.26M
47.36%
64.91M
4.25%
119.73M
84.48%
108.75M
9.17%
73.79M
32.15%
60.76M
17.65%
87.73M
44.38%
other expenses
-9.42M
-
1.16M
112.30%
1.17M
0.60%
2.63M
125.49%
8.08M
207.65%
7.70M
4.75%
2.42M
68.55%
4.45M
83.60%
3K
99.93%
cost and expenses
14.37M
-
37.59M
161.63%
55.52M
47.70%
82.00M
47.69%
98.71M
20.39%
156.07M
58.10%
143.74M
7.90%
111.03M
22.76%
91.74M
17.37%
127.99M
39.51%
operating expenses
14.37M
-
37.59M
161.63%
55.52M
47.70%
82.00M
47.69%
98.71M
20.39%
156.07M
58.10%
143.74M
7.90%
111.03M
22.76%
91.74M
17.37%
123.55M
34.67%
interest expense
332K
-
976K
193.98%
-390K
-
1.79M
559.49%
ebitda
-14.18M
-
-20.25M
42.80%
-41.30M
103.91%
-71.86M
74.01%
-91.09M
26.76%
-51.68M
43.27%
31.20M
160.37%
-73.62M
335.95%
-50.84M
30.94%
126.45M
348.75%
operating income
-14.37M
-
-20.25M
40.98%
-41.30M
103.91%
-71.86M
74.01%
-91.09M
26.76%
-51.68M
43.27%
27.38M
152.99%
-73.62M
368.84%
-50.84M
30.94%
122.01M
340.01%
depreciation and amortization
184K
-
600K
226.09%
612K
2%
1.59M
160.62%
2.12M
32.73%
2.77M
30.61%
3.82M
38.05%
5.17M
35.32%
6.19M
19.86%
4.44M
28.27%
total other income expenses net
-1.95M
-
-9.42M
382.97%
1.16M
112.30%
1.17M
0.60%
2.63M
125.49%
8.08M
207.65%
9.36M
15.78%
2.42M
74.13%
4.45M
83.60%
11.72M
163.76%
income before tax
-16.32M
-
-29.67M
81.85%
-40.14M
35.28%
-70.70M
76.12%
-88.47M
25.14%
-43.60M
50.72%
36.74M
184.27%
-71.20M
293.78%
-46.39M
34.84%
133.74M
388.28%
income tax expense
-600K
-
52K
108.67%
-1.59M
3,167.31%
-180K
88.71%
-2.77M
1,436.11%
-1.66M
40%
-5.17M
211.33%
16K
100.31%
1.41M
8,700%
net income
-16.32M
-
-29.67M
81.85%
-40.19M
35.46%
-70.70M
75.90%
-88.29M
24.88%
-40.83M
53.75%
36.74M
189.98%
-66.03M
279.72%
-46.41M
29.72%
132.33M
385.14%
weighted average shs out
14.71M
-
4.19M
71.51%
25.30M
503.70%
26.80M
5.93%
32.07M
19.63%
35.90M
11.95%
37.13M
3.44%
37.67M
1.44%
38.36M
1.83%
43.02M
12.16%
weighted average shs out dil
14.71M
-
4.19M
71.51%
25.30M
503.70%
26.80M
5.93%
32.07M
19.63%
35.90M
11.95%
37.35M
4.04%
37.67M
0.86%
38.36M
1.83%
44.57M
16.20%
eps
-1.11
-
-7.08
537.84%
-1.59
77.54%
-2.64
66.04%
-2.75
4.17%
-1.14
58.55%
0.99
186.84%
-1.75
276.77%
-1.21
30.86%
3.08
354.55%
epsdiluted
-1.11
-
-7.08
537.84%
-1.59
77.54%
-2.64
66.04%
-2.75
4.17%
-1.14
58.55%
0.98
185.96%
-1.75
278.57%
-1.21
30.86%
2.97
345.45%

All numbers in USD (except ratios and percentages)